Back to Search
Start Over
Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCT.
- Source :
-
Leukemia research [Leuk Res] 2021 May; Vol. 104, pp. 106579. Date of Electronic Publication: 2021 Mar 30. - Publication Year :
- 2021
- Subjects :
- Adult
Aged
Allografts
Antibodies, Bispecific adverse effects
Female
Humans
Male
Middle Aged
Neoplasm, Residual
Antibodies, Bispecific administration & dosage
Hematopoietic Stem Cell Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma blood
Precursor Cell Lymphoblastic Leukemia-Lymphoma pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1873-5835
- Volume :
- 104
- Database :
- MEDLINE
- Journal :
- Leukemia research
- Publication Type :
- Report
- Accession number :
- 33831656
- Full Text :
- https://doi.org/10.1016/j.leukres.2021.106579